Mucocutaneous Presentations of Critical and Non-Critical Admitted COVID-19 Patients and Vaccine-Associated Dermatoses: A Study from Iran

    May 2023 in “ Dermatology Reports ”
    Afsaneh Sadeghzadeh‐Bazargan, Azadeh Goodarzi
    Image of study
    TLDR The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.
    The study "Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses" reported on 121 cases of COVID-19 patients over a 14-month period, who presented with various skin conditions. These conditions were categorized into 12 groups: generalized papulopustular eruptions (3 patients), erythroderma (4 patients), maculopapular lesions (16 patients), mucosal lesions (8 patients), urticarial lesions and angioedema (16 patients), vascular injuries (22 patients), vesiculobullous lesions (12 patients), new onset or aggravated dermatoses (9 patients), nail changes (3 patients), hair loss (2 patients), non-specific mucocutaneous problems (16 patients), and vaccine-associated dermatoses (10 patients). The study emphasized the importance of rapid diagnosis of these skin conditions, as they often indicate internal organ damage and could be life-threatening. Extensive mucocutaneous lesions with vascular components or vesiculobullous erosive lesions associated with any cutaneous rash were identified as potential signs of a serious systemic event.
    Discuss this study in the Community →

    Research cited in this study

    3 / 3 results

    Related Community Posts Join

    6 / 1000+ results

      community Physician here AMA – 30M oral Fin 1-1.25 mg daily

      in Update  47 upvotes 2 years ago
      Hair loss treatments, specifically the use of finasteride, microneedling and potentially oral minoxidil. People discussed their experiences with finasteride, its effects on sexual behaviors, as well as potential solutions such as tadalafil or using other growth factor signal peptides for hope in curing male pattern baldness.

      community 5 months of oral minoxidil and oral dutasteride.

      in Progress Pictures  157 upvotes 1 year ago
      The conversation discusses the positive effects of taking 5 mg oral minoxidil and 0.5 mg oral dutasteride every other day for hair loss, with one user reporting thicker beard and eyebrows and improved appearance. Another user expresses frustration about not being able to access the treatment in Germany, while a different user mentions experiencing no side effects.

      community The theory that explains everything. Please help me make this big!

      in Research/Science  2449 upvotes 4 years ago
      The post and conversation are about the role of the enzyme 3alpha-hydroxysteroid reductase in hair loss and the potential of compounds like procyanidin B2 and sulforaphane to boost its activity for hair regrowth. Further research is needed to develop effective treatments based on this theory.

      community Hair Loss Inflammation Prevention Stack

      in Research/Science  42 upvotes 1 week ago
      The conversation discusses a hair loss and scalp care routine involving ciclopirox shampoo, benzoyl peroxide, clindamycin gel, clobetasol propionate, and calcipotriol to manage seborrheic dermatitis, folliculitis, and inflammation. It also touches on the role of diet and other treatments like oral minoxidil and pioglitazone for scalp health.

    Similar Research

    5 / 1000+ results